Invasive breast carcinoma - IARC

3061. Wargotz ES, Norris HJ (1990).
Metaplastic carcinomas of the breast. IV.
Squamous cell carcinoma of ductal origin.
Cancer 65: 272-276.
3062. Wargotz ES, Norris HJ (1990).
Metaplastic carcinomas of the breast: V.
Metaplastic carcinoma with osteoclastic
giant cells. Hum Pathol 21: 1142-1150.
3063. Wargotz ES, Norris HJ, Austin RM,
Enzinger FM (1987). Fibromatosis of the
breast. A clinical and pathological study of
28 cases. Am J Surg Pathol 11: 38-45.
3064. Wargotz ES, Silverberg SG (1988).
Medullary carcinoma of the breast: a clinicopathologic
study with appraisal of current
diagnostic criteria. Hum Pathol 19:
1340-1346.
3065. Warner E, Foulkes W, Goodwin P,
Meschino W, Blondal J, Paterson C,
Ozcelik H, Goss P, Allingham-Hawkins D,
Hamel N, Di Prospero L, Contiga V, Serruya
C, Klein M, Moslehi R, Honeyford J, Liede
A, Glendon G, Brunet JS, Narod S (1999).
Prevalence and penetrance of BRCA1 and
BRCA2 gene mutations in unselected
Ashkenazi Jewish women with breast cancer.
J Natl Cancer Inst 91: 1241-1247.
3066. Warner NE (1969). Lobular carcinoma
of the breast. Cancer 23: 840-846.
3067. Watanabe Y, Nakajima H, Nozaki K,
Ueda H, Obata K, Hoshiai H, Noda K (2001).
Clinicopathologic and immunohistochemical
features and microsatellite status of
endometrial cancer of the uterine isthmus.
Int J Gynecol Pathol 20: 368-373.
3068. Waterhouse J, Muir CS, Correa P,
Powell J (1976). Cancer Incidence in Five
Continents (IARC Scientific Publications
n°15). IARC: Lyon.
3069. Watkin W, Silva EG, Gershenson DM
(1992). Mucinous carcinoma of the ovary.
Pathologic prognostic factors. Cancer 69:
208-212.
3070. Watson P, Lin KM, Rodriguez-Bigas
MA, Smyrk T, Lemon S, Shashidharan M,
Franklin B, Karr B, Thorson A, Lynch HT
(1998). Colorectal carcinoma survival
among hereditary nonpolyposis colorectal
carcinoma family members. Cancer 8 3 :
259-266.
3071. Watson P, Vasen HF, Mecklin JP,
Jarvinen H, Lynch HT (1994). The risk of
endometrial cancer in hereditary nonpolyposis
colorectal cancer. Am J Med 96: 516-
520.
3072. Watt AC, Haggar AM, Krasicky GA
(1984). Extraosseous osteogenic sarcoma
of the breast: mammographic and pathologic
findings. Radiology 150: 34.
3073. Waxman M (1979). Pure and mixed
Brenner tumors of the ovary: clinicopathologic
and histogenetic observations.
Cancer 43: 1830-1839.
3074. Waxman M, Vuletin JC, Urcuyo R,
Belling CG (1979). Ovarian low-grade stromal
sarcoma with thecomatous features: a
critical reappraisal of the so-called "malignant
thecoma". Cancer 44: 2206-2217.
3075. Way S (1948). Primary carcinoma of
the vagina. J Obstet Br Emp 55: 739.
3076. Webb JC, Key CR, Qualls CR, Smith
HO (2001). Population-based study of
microinvasive adenocarcinoma of the
uterine cervix. Obstet Gynecol 97: 701-706.
3077. Webb LA, Young JR (1996). Case
report: haemangioma of the breast--
appearances on mammography and ultrasound.
Clin Radiol 51: 523-524.
3078. Webb MJ, Symmonds RE, Weiland
LH (1974). Malignant fibrous histiocytoma
of the vagina. Am J Obstet Gynecol 119:
190-192.
3079. Weber AM, Hewett WF, Gajewski
WH, Curry SL (1993). Malignant mixed mullerian
tumors of the fallopian tube.
Gynecol Oncol 50: 239-243.
3080. Wei LH, Huang CY, Cheng SP, Chen
CA, Hsieh CY (2001). Carcinosarcoma of
ovary associated with previous radiotherapy.
Int J Gynecol Cancer 11: 81-84.
3081. Weidner N (1990). Benign breast
lesions that mimic malignant tumors:
analysis of five distinct lesions. S e m i n
Diagn Pathol 7: 90-101.
3082. Weidner N, Semple JP (1992).
Pleomorphic variant of invasive lobular
carcinoma of the breast. Hum Pathol 23:
1167-1171.
3083. Weigand RA, Isenberg WM, Russo J,
Brennan MJ, Rich MA (1982). Blood vessel
invasion and axillary lymph node involvement
as prognostic indicators for human
breast cancer. Cancer 50: 962-969.
3084. Weinberg E, Hoisington S, Eastman
AY, Rice DK, Malfetano J, Ross JS (1993).
Uterine cervical lymphoepithelial-like carcinoma.
Absence of Epstein-Barr virus
genomes. Am J Clin Pathol 99: 195-199.
3085. Weir MM, Bell DA, Young RH (1997).
Transitional cell metaplasia of the uterine
cervix and vagina: an underrecognized
lesion that may be confused with highgrade
dysplasia. A report of 59 cases. Am
J Surg Pathol 21: 510-517.
3086. Weiss SW (1994). Histological Typing
of Soft Tissue Tumours. 2nd ed. Springer:
Berlin Heidelberg, New York.
3087. Weiss SW, Tavassoli FA (1988).
Multicystic mesothelioma. An analysis of
pathologic findings and biologic behavior
in 37 cases. Am J Surg Pathol 12: 737-746.
3088. Weissberg JB, Huang DD, Swift M
(1998). Radiosensitivity of normal tissues in
ataxia-telangiectasia heterozygotes . Int J
Radiat Oncol Biol Phys 42: 1133-1136.
3089. Weitmann HD, Knocke TH, Kucera H,
Potter R (2001). Radiation therapy in the
treatment of endometrial stromal sarcoma.
Int J Radiat Oncol Biol Phys 49: 739-748.
3090. Weitzner S, Nascimento AG, Scanlon
LJ (1979). Intramammary granular cell
myoblastoma. Am Surg 45: 34-37.
3091. Wellings SR, Jensen HM, Marcum
RG (1975). An atlas of subgross pathology
of the human breast with special reference
to possible precancerous lesions. J Natl
Cancer Inst 55: 231-273.
3092. Wells CA, Ferguson DJ (1988).
Ultrastructural and immunocytochemical
study of a case of invasive cribriform
breast carcinoma. J Clin Pathol 41: 17-20.
3093. Wells CA, McGregor IL, Makunura
CN, Yeomans P, Davies JD (1995).
Apocrine adenosis: a precursor of aggres -
sive breast cancer? J Clin Pathol 48: 737-
742.
3094. Wells CA, Nicoll S, Ferguson DJ
(1986). Adenoid cystic carcinoma of the
breast: a case with axillary lymph node
metastasis. Histopathology 10: 415-424.
3095. Wen WH, Reles A, Runnebaum IB,
Sullivan-Halley J, Bernstein L, Jones LA,
Felix JC, Kreienberg R, el Naggar A, Press
MF (1999). p53 mutations and expression in
ovarian cancers: correlation with overall
survival. Int J Gynecol Pathol 18: 29-41.
3096. Weng L, Brown J, Eng C (2001). PTEN
induces apoptosis and cell cycle arrest
through phosphoinositol-3-kinase/Aktdependent
and -independent pathways.
Hum Mol Genet 10: 237-242.
3097. Weng LP, Brown JL, Baker KM,
Ostrowski MC, Eng C (2002). PTEN blocks
insulin-mediated ETS-2 phosphorylation
through MAP kinase, independently of the
phosphoinositide 3-kinase pathway. Hum
Mol Genet 11: 1687-1696.
3098. Weng LP, Smith WM, Brown JL, Eng
C (2001). PTEN inhibits insulin-stimulated
MEK/MAPK activation and cell growth by
blocking IRS-1 phosphorylation and IRS-
1/Grb-2/Sos complex formation in a breast
cancer model. Hum Mol Genet 10: 605-616.
3099. Werling RW, Hwang H, Yaziji H, Gown
AM (2003). Immunohistochemical distinction
of invasive from noninvasive breast
lesions: a comparative study of p63 versus
calponin and smooth muscle myosin heavy
chain. Am J Surg Pathol 27: 82-90.
3100. Werner M, Mattis A, Aubele M,
Cummings M, Zitzelsberger H, Hutzler P,
Hofler H (1999). 20q13.2 amplification in
intraductal hyperplasia adjacent to in situ
and invasive ductal carcinoma of the
breast. Virchows Arch 435: 469-472.
3101. Werness BA, Dicioccio RA (2002).
Transitional cell ovarian carcinoma in a
BRCA1 mutation carrier. Obstet Gynecol
100: 385.
3102. Werness BA, Ramus SJ, Whittemore
AS, Garlinghouse-Jones K, Oakley-Girvan
I, Dicioccio RA, Tsukada Y, Ponder BA,
Piver MS (2000). Histopathology of familial
ovarian tumors in women from families
with and without germline BRCA1 mutations.
Hum Pathol 31: 1420-1424.
3103. Werness BA, Ramus SJ, Whittemore
AS, Garlinghouse-Jones K, Oakley-Girvan
I, Dicioccio RA, Tsukada Y, Ponder BA,
Piver MS (2000). Primary ovarian dysgerminoma
in a patient with a germline BRCA1
mutation. Int J Gynecol Pathol 19: 390-394.
3104. West M, Blanchette C, Dressman H,
Huang E, Ishida S, Spang R, Zuzan H, Olson
JA Jr., Marks JR, Nevins JR (2001).
Predicting the clinical status of human
breast cancer by using gene expression
profiles. Proc Natl Acad Sci USA 98: 11462-
11467.
3 1 0 4 a . Westenend PJ, Liem SJ (2001).
Adenosis tumor of the breast containing
ductal carcinoma in situ, a pitfall in core
needle biopsy. Breast J 7: 200-201.
3105. Wheeler DT, Bell KA, Kurman RJ,
Sherman ME (2000). Minimal uterine
serous carcinoma: diagnosis and clinicopathologic
correlation. Am J Surg Pathol
24: 797-806.
3106. Wheeler JE, Enterline HT (1976).
Lobular carcinoma of the breast in situ and
infiltrating. Pathol Annu 11: 161-188.
3107. Wheeler JE, Enterline HT, Roseman
JM, Tomasulo JP, McIlvaine CH, Fitts WT
Jr., Kirshenbaum J (1974). Lobular carcinoma
in situ of the breast. Long-term followup.
Cancer 34: 554-563.
3108. Wheelock JB, Goplerud DR, Dunn LJ,
Oates JF, III (1984). Primary carcinoma of
the Bartholin gland: a report of ten cases.
Obstet Gynecol 63: 820-824.
3109. Wheelock JB, Krebs HB, Schneider
V, Goplerud DR (1985). Uterine sarcoma:
analysis of prognostic variables in 71
cases. Am J Obstet Gynecol 151: 1016-
1022.
3110. Whiteman DC, Murphy MF,
Verkasalo PK, Page WF, Floderus B,
Skytthe A, Holm NV (2000). Breast cancer
risk in male twins: joint analyses of four
twin cohorts in Denmark, Finland, Sweden
and the United States. Br J Cancer 83:
1231-1233.
3111. WHO Technical Report Series (1983).
WHO Scientific Group: Gestional trophoblastic
diseases. WHO:
3112. Wick MR, Goellner JR, Wolfe JT, III,
Su WP (1985). Vulvar sweat gland carcinomas.
Arch Pathol Lab Med 109: 43-47.
3113. Wick MR, Lillemoe TJ, Copland GT,
Swanson PE, Manivel JC, Kiang DT (1989).
Gross cystic disease fluid protein-15 as a
marker for breast cancer: immunohistochemical
analysis of 690 human neoplasms
and comparison with alpha-lactalbumin.
Hum Pathol 20: 281-287.
3114. Wijnen J, de Leeuw W, Vasen H, van
der Klift H, Moller P, Stormorken A,
Meijers-Heijboer H, Lindhout D, Menko F,
Vossen S, Moslein G, Tops C, Brocker-
Vriends A, Wu Y, Hofstra R, Sijmons R,
Cornelisse C, Morreau H, Fodde R (1999).
Familial endometrial cancer in female carriers
of MSH6 germline mutations. Nat
Genet 23: 142-144.
3115. Wijnen J, Khan PM, Vasen H, Menko
F, van der Klift H, van den Broek M,
Leeuwen-Cornelisse I, Nagengast F,
Meijers-Heijboer EJ, Lindhout D, Griffioen
G, Cats A, Kleibeuker J, Varesco L, Bertario
L, Bisgaard ML, Mohr J, Kolodner R, Fodde
R (1996). Majority of hMLH1 mutations
responsible for hereditary nonpolyposis
colorectal cancer cluster at the exonic
region 15-16. Am J Hum Genet 58: 300-307.
3116. Wijnen J, van der Klift H, Vasen H,
Khan PM, Menko F, Tops C, Meijers HH,
Lindhout D, Moller P, Fodde R (1998). MSH2
genomic deletions are a frequent cause of
HNPCC. Nat Genet 20: 326-328.
3117. Wijnen JT, Vasen HF, Khan PM,
Zwinderman AH, van der Klift H, Mulder A,
Tops C, Moller P, Fodde R (1998). Clinical
findings with implications for genetic testing
in families with clustering of colorectal
cancer. N Engl J Med 339: 511-518.
3118. Wijnmaalen A, van Ooijen B, van Geel
BN, Henzen-Logmans SC, Treurniet-
Donker AD (1993). Angiosarcoma of the
breast following lumpectomy, axillary
lymph node dissection, and radiotherapy
for primary breast cancer: three case
reports and a review of the literature. Int J
Radiat Oncol Biol Phys 26: 135-139.
3119. Wilkinson EJ (2000). Protocol for the
examination of specimens from patients
with carcinomas and malignant
melanomas of the vulva: a basis for checklists.
Cancer Committee of the American
College of Pathologists. Arch Pathol Lab
Med 124: 51-56.
3120. Wilkinson EJ (2002). Premalignant
and Malignant Tumours of the vulva. In:
Blaustein's Pathology of the Female
Genital Tract. 5th ed. Springer-Verlag:
New York.
3121. Wilkinson EJ, Brown H (2002). Vulvar
Paget disease of urothelial origin: a report
of three cases and proposed classification
of vulvar Paget disease. Hum Pathol 33:
549-554.
3122. Wilkinson EJ, Croker BP, Friedrich EG
Jr., Franzini DA (1988). Two distinct pathologic
types of giant cell tumor of the vulva.
A report of two cases. J Reprod Med 33:
519-522.
3123. Wilkinson EJ, Friedrich EG Jr., Fu YS
(1981). Multicentric nature of vulvar carcinoma
in situ. Obstet Gynecol 58: 69-74.
3124. Wilkinson EJ, Stone IK (1994). Atlas
of Vulvar Disease. Williams and WIlkins:
Baltimore, Maryland.
References 421